Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Oct 31, 2024 | 25.84 | 0.00 |
Regis | RGS | Oct 31, 2024 | 23.48 | -3.61 |
Regulus Therapeutics | RGLS | Oct 31, 2024 | 1.46 | -6.41 |
Reinsurance Group of America | RGA | Oct 31, 2024 | 211.08 | -1.79 |
REIT Index ETF Vanguard | VNQ | Oct 31, 2024 | 94.15 | -1.69 |
Reitar Logtech | RITR | Oct 31, 2024 | 7.22 | 0.00 |
Rekor Systems | REKR | Oct 31, 2024 | 1.05 | -0.94 |
Relay Therapeutics | RLAY | Oct 31, 2024 | 5.63 | -1.31 |
Reliance | RS | Oct 31, 2024 | 286.34 | -1.12 |
Reliance Global | RELI | Oct 31, 2024 | 2.38 | +3.03 |
Relmada Therapeutics | RLMD | Oct 31, 2024 | 3.48 | -0.57 |
RELX ADR | RELX | Oct 31, 2024 | 46.22 | -1.47 |
Remitly Global | RELY | Oct 31, 2024 | 17.98 | +17.82 |
Renaissance Ipo ETF | IPO | Oct 31, 2024 | 44.74 | -1.39 |
RenaissanceRe | RNR | Oct 31, 2024 | 262.40 | -1.87 |
RenaissanceRe G Pref | RNR-G | Oct 31, 2024 | 18.37 | -0.05 |
RenaissanceRe Holding F Pref | RNR-F | Oct 31, 2024 | 24.15 | -0.37 |
Renalytix ADR | RNLX | Oct 31, 2024 | 0.20 | 0.00 |
Renasant | RNST | Oct 31, 2024 | 34.11 | -1.56 |
Reneo Pharmaceuticals | RPHM | Oct 31, 2024 | 1.82 | 0.00 |
ReNew Energy Global A Shares | RNW | Oct 31, 2024 | 5.66 | -3.08 |
Renn Fund | RCG | Oct 31, 2024 | 2.16 | -1.82 |
Renovaro Biosciences | RENB | Oct 31, 2024 | 0.53 | -1.46 |
RenovoRx | RNXT | Oct 31, 2024 | 1.00 | -0.20 |
Rent The Runway A | RENT | Oct 31, 2024 | 9.18 | -8.02 |
Rentokil Initial ADR | RTO | Oct 31, 2024 | 25.35 | +0.68 |
Repare Therapeutics | RPTX | Oct 31, 2024 | 3.35 | -2.90 |
Repay A | RPAY | Oct 31, 2024 | 7.96 | -0.56 |
Repligen | RGEN | Oct 31, 2024 | 134.27 | -1.55 |
Replimune Group | REPL | Oct 31, 2024 | 11.76 | -2.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.